checkAd

     101  0 Kommentare iFabric Corp. Receives FDA Medical Device Registration for Apparel Products Utilizing Multiple Textile Technologies - Seite 2

    A description of additional risk factors that may cause actual results to differ materially from forward-looking information can be found in the Company's annual information form dated April 1, 2024 and other filings with the Canadian securities regulators available under the Company's profile on SEDAR+ at www.sedarplus.ca. Although the Company has attempted to identify important factors that could cause actual results to differ materially from those contained in forward-looking information, there may be other factors that cause results not to be as anticipated, estimated or intended.

    Forward-looking statements are based on the opinions and estimates of management as of the date such statements are made. Readers are cautioned not to place undue reliance on these statements as the Company's actual results, performance, or achievements may differ materially from any future results, performance or achievements expressed or implied by such forward-looking statements if known or unknown risks, uncertainties or other factors affect the Company's business, or if the Company's estimates or assumptions prove inaccurate. Therefore, the Company cannot provide any assurance that forward-looking statements will materialize. Such information, although considered reasonable by management at the time of preparation, may prove to be incorrect and actual results may differ materially from those anticipated.

    Any financial outlook or future oriented financial information in this news release, as defined by applicable securities legislation, has been approved by management of iFabric. Such financial outlook or future oriented financial information is provided for the purpose of providing information about management's reasonable expectations as to the anticipated results of its proposed business activities. Readers are cautioned that reliance on such information may not be appropriate for other purposes. The Company assumes no obligation to update or revise any forward-looking statements, whether as a result of new information, future events or any other reason except as required by applicable securities laws.

    FOR FURTHER INFORMATION please contact:

    Hylton Karon, President and CEO
    Tel: 905.752.0566 ext 201
    Email: hyltonk@ifabriccorp.com

    Hilton Price, CFO
    Tel: 647.465.6161
    Email: hilton.price@rogers.com
    Website: www.ifabriccorp.com

    Neither the TSX Exchange nor its Regulations Services Provider (as that term is defined in the policies of the TSX Exchange) accepts responsibility for the adequacy or accuracy of this press release.

    SOURCE: iFabric Corp



    View the original press release on accesswire.com


    The iFabric Stock at the time of publication of the news with a fall of -1,65 % to 1,190CAD on Toronto stock exchange (29. April 2024, 21:59 Uhr).
    Seite 2 von 2


    Aktuelle Themen


    Accesswire
    0 Follower
    Autor folgen
    Mehr anzeigen
    We’re a newswire service standout and fast becoming an industry disruptor. We provide regional, national and global news to thousands of clients around the world. We’re also leading the way in social engagement, targeting and analytics.
    Mehr anzeigen

    Verfasst von Accesswire
    iFabric Corp. Receives FDA Medical Device Registration for Apparel Products Utilizing Multiple Textile Technologies - Seite 2 MARKHAM, ON / ACCESSWIRE / April 30, 2024 / iFabric Corp. ("iFabric" or the "Company") (TSX:IFA.TO)(OTCQX:IFABF), a leading provider of innovative apparel and textile technologies, announces its wholly-owned subsidiary company, Intelligent Fabric …

    Schreibe Deinen Kommentar

    Disclaimer